Publications by authors named "Petr Moravek"

Claim this Profile
R
Renal cell carcinoma with intracardiac tumor thrombus extension: Radical surgery yields 2 years of postoperative survival in a single-center study over a period of 30 years.
Pavel Zacek, Milos Brodak, Jan Gofus, Jan Dominik, Petr Moravek

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival after radical surgery for renal cell carcinoma with tumour thrombus extension into the right atrium.
Jan Dominik, Petr Moravek, Pavel Zacek, Jan Vojacek, Miroslav Brtko

BJU Int· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic colorectal carcinoma and kidney tumors: a report of four cases.
Bohuslav Melichar, Petr Morávek, Alexander Ferko, Miroslav Podhola

Tumori· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy.
Martin Dolezel, Karel Odrazka, Miloslava Vaculikova, Jaroslav Vanasek, Jana Sefrova, Petr Moravek

Strahlenther Onkol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous regression of renal cell carcinoma lung metastases in a patient with psoriasis.
Bohuslav Melichar, Jaroslava Vanecková, Petr Morávek, Hana Urminská, Miroslav Podhola

Acta Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of serum levels of angiogenin, ENA-78 and GRO chemokines in patients with renal cell carcinoma (RCC) in the course of the treatment.
Dagmar Hlávková, Otakar Kopecký, Sárka Lukesová, Vladimíra Vroblová, Ctirad Andrýs

Acta Medica (Hradec Kralove)· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma.
Otakar Kopecký, Sárka Lukesová, Vladimíra Vroblová, Doris Vokurková, Petr Morávek

Acta Medica (Hradec Kralove)· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
Karel Odrazka, Miloslava Vaculikova, Martin Dolezel, Jiri Petera, Petr Moravek

Oncol Rep· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic profile of bone metastases in renal cell carcinoma.
Kerstin Junker, Imre Romics, Attila Szendroi, Peter Riesz, Petr Moravek

Eur Urol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic subtyping of renal cell carcinoma by comparative genomic hybridization.
Kerstin Junker, Gregor Weirich, Mahul B Amin, Petr Moravek, Winfried Hindermann

Recent Results Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer.
Karel Odrazka, Miloslava Vaculikova, Jiri Petera, Petr Moravek, Petr Prosvic

Int J Urol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis